Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership


All
13F
13D/G
Other
Tags
CC transcript
ASTRAZENECA PLC (AZN) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "ASTRAZENECA SETTLES NEXIUM LIABILITY LITIGATIONS"
10/02/2023 6-K Quarterly results
08/01/2023 6-K Quarterly results
07/28/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
07/28/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "ALEXION ENTERS GENE THERAPY AGREEMENT WITH PFIZER"
07/17/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "BEYFORTUS APPROVED IN US FOR INFANT RSV PREVENTION"
07/03/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "TOTAL VOTING RIGHTS"
07/03/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "DATO-DXD SIGNIFICANTLY IMPROVED PFS IN LUNG CANCER"
06/09/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "NIRSEVIMAB RECOMMENDED FOR INFANT RSV PROTECTION"
06/09/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "ASTRAZENECA AGREEMENT WITH QUELL THERAPEUTICS"
06/02/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "IMFINZI IMPROVED PCR IN GASTRIC AND GEJ CANCERS"
06/01/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "BLOCK LISTING INTERIM REVIEW"
06/01/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "TOTAL VOTING RIGHTS"
06/01/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "LYNPARZA APPROVED IN US FOR BRCAM PROSTATE CANCER"
05/26/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "IMFINZI + LYNPARZA PROLONGED PFS IN ENDOMETRIAL CANCER"
05/17/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "TAGRISSO PLUS CHEMO IMPROVED PFS IN LUNG CANCER"
05/09/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "DIRECTOR/PDMR SHAREHOLDING"
05/09/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FARXIGA EXTENDED IN THE US FOR HEART FAILURE"
05/02/2023 6-K Quarterly results
05/02/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "ODAC VOTE ON LYNPARZA COMBO IN PROSTATE CANCER"
05/02/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "DIRECTOR/PDMR SHAREHOLDING"
04/27/2023 6-K Quarterly results
04/27/2023 6-K Quarterly results
04/27/2023 6-K Quarterly results
04/27/2023 6-K Quarterly results
04/26/2023 6-K Quarterly results
04/05/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "LYNPARZA + IMFINZI MET ENDPOINT IN OVARIAN CANCER"
04/03/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "TOTAL VOTING RIGHTS"
04/03/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "ULTOMIRIS RECOMMENDED FOR NMOSD EU APPROVAL"
03/30/2023 6-K Quarterly results
03/27/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "DIRECTOR/PDMR SHAREHOLDING"
03/22/2023 6-K Quarterly results
03/22/2023 6-K Quarterly results
03/09/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "IMFINZI IMPROVED EFS IN RESECTABLE LUNG CANCER"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy